Cardiopulmonary resuscitation


Cardiac arrest during anesthesia

Incidence of cardiac arrest during anesthesia

This chapter provides an overview of incidence, etiologies and outcomes of pediatric perioperative cardiac arrest, the physiology of cardiopulmonary resuscitation, current therapeutic recommendations as well as physiologic and scientific underpinnings of those recommendations. The 2020 American Heart Association updates are presented thoughout the chapter and summarized in Box 57.1 . A perioperative cardiac arrest is an event that requires chest compressions while a patient is under an anesthesiologist’s care during the intraoperative or immediate postoperative period. The causes of perioperative cardiac arrest include factors related to the anesthesia, the surgical procedure, or patient comorbidities. Anesthesia-related cardiac arrest and mortality in children are infrequent events, and the reporting of available data is challenging to interpret. First, there is considerable variation in how reports define anesthesia-related cardiac arrest. The definitions vary from arrests in which anesthesia is the major causative factor to arrests in which anesthesia has any role. Second, the phases of care involved vary from including only the intraoperative period to including premedication through the first 24 hours (or longer) of postoperative care. One study looked at anesthesia-related deaths up to 30 days postoperatively ( ). Third is the possible gross underestimation of anesthesia-related cardiac arrest and mortality when voluntary reporting is involved. Fourth is that studies that rely on cardiac arrest as the inciting event for reporting may miss cases in which anesthesia-related cardiac arrest and mortality occurred postoperatively without capturing the responsible intraoperative events ( ). The final challenge in interpreting this literature is the variation in whether studies include arrests that occur during cardiac surgery. This absence of standardized methods of reporting combined with the infrequent occurrence of perioperative arrests contributes to a lack of precise information regarding the incidence and risk factors for anesthesia-related cardiac arrest and death in children.

BOX 57.1
Summary of AHA BLS and PALS Updates

  • Respiratory rate now 1 breath every 2–3 seconds

  • Emphasis on early administration of epinephrine for nonshockable rhythm

  • Use EEG and treat seizures after ROSC

  • Sepsis IVF bolus 10 or 20 mL/kg

  • Sepsis vasopressor: Epi or Norepi > Dopa

  • Naloxone: Consider IM/IN for suspected opioid OD

  • Myocarditis: Consider early ECMO

  • Post resuscitation checklist

  • Education: In situ and booster training recommended

Table 57.1 shows the reported incidence of pediatric perioperative cardiac arrest for all types of procedures, including cardiac surgery. The overall incidence of perioperative cardiac arrest for children of all age groups and undergoing all types of surgeries ranged from 5.1 to 22.9 per 10,000 procedures ( ; ; ; ; ; ; ; ). Notably, studies that are more recent have larger patient cohorts and lower incidences of perioperative arrest. Two reviews of >250,000 and >1,000,000 pediatric anesthetics both reported an incidence of 5 perioperative arrests per 10,000 anesthetics ( ; ). Studies that excluded cardiac surgery had lower overall incidences that ranged from 2.9 to 7.4 per 10,000 procedures ( ; ; ). Studies that reported on children undergoing cardiac surgery have the highest incidence of perioperative cardiac arrest, from 79 to 127 per 10,000 procedures ( ; ). When only anesthesia-related cardiac arrest is reported, the arrest incidence for all types of surgery (including cardiac) ranges from 0.8 to 4.6 per 10,000 procedures.

TABLE 57.1
Incidence of Pediatric Perioperative Cardiac Arrest by Age Group for All Types of Surgery
Author, Year Years of Study Age Range Number of Patients per Age Group Cases of Cardiac Arrest per Age Group Incidence of Cardiac Arrest per 10,000 Overall Incidence of Cardiac Arrest per 10,000 (ages 0–18 yr)
1982–1987 <1 mo
1 mo–1 yr
1–5 yr
6–10 yr
>11 yr
Total
361
2544
13,484
7184
5647
29,220
3
4
7
4
3
21
83.1
15.7
5.2
5.6
5.3
7.2
7.2
1996–2004 <1 mo
1 mo–1 yr
1–12 yr
13–17 yr
Total
697
2368
8856
3332
15,253
14
10
8
3
35
200.9
42.2
9.0
9.0
22.9
22.9
1988–2005 <1 mo
1 mo–1 yr
1–3 yr
4–9 yr
10–18 yr
Total
1451
7807
19,205
25,650
38,768
92,881
23
18
15
11
13
80
158
23
7.8
4.3
3.4
8.6
8.6
2005–2010 <1 mo
1 mo–1 yr
1–12 yr
13–17 yr
Total
390
760
7341
2158
10,649
7
7
8
0
22
179.5
92.1
10.9
0
20.7
20.7
2000–2011 <1 mo
1–3 mo
3–6 mo
6 mo–1 yr
1–18 yr
Total
5701
6177
8184
18,965
237,182
276,209
13
11
10
7
31
142
21.05
17.81
12.22
3.69
1.31
5.1
5.1
<1 mo
1–5 mo
6–11 mo
1–3 yr
4–8 yr
9–12 yr
13–17 yr
Total
19,441
51,307
66,206
268,430
294,635
145,294
161,372
1,006,685
90
103
76
110
58
30
64
531
46.3
20.1
11.5
4.1
2
2.1
4
5.3
5.3

As Table 57.1 indicates, young age is a consistent risk factor for pediatric perioperative cardiac arrest. The highest risk is in infants <1 month of age, followed by those <1 year ( ; ; ; ; ; ; ; ; ). The Pediatric Perioperative Cardiac Arrest (POCA) Registry is a voluntary reporting registry formed in 1994 to investigate the causes and outcomes of pediatric perioperative cardiac arrest and death (≤18 years of age) in the operating room or postanesthesia care unit (PACU). A POCA registry analysis showed that 56% of anesthesia-related cardiac arrests were infants <1 year during 1994 to 1997, and that percentage fell to 38% during 1998 to 2004. They attribute this decrease to a switch from halothane to sevoflurane, which is associated with less bradycardia and myocardial depression ( ). Unfortunately, infants <1 year continue to have the highest rate of perioperative cardiac arrest. A large review found a threefold increase in perioperative cardiac arrest in children ≤6 months old compared with children >6 months old ( ). If adult perioperative arrests are included, infants have an incidence of perioperative cardiac arrest that is over four times the second highest age group (>80 years old). Fig. 57.1 shows the incidence and outcomes of perioperative cardiac arrest by age as reported to the National Anesthesia Clinical Outcomes Registry from 2010 to 2013 ( ).

Fig. 57.1, Cardiac arrest data by age group subdivided by outcome, expressed as arrests per 10,000 cases.

The patient’s preoperative physical condition (stratified by their American Society of Anesthesiologists [ASA] physical status classification) also influences the risk of perioperative cardiac arrest. The risk of intraoperative cardiac arrest is increased in patients with an ASA physical status ≥3 ( ; ; ; ; ; ; ; ; ; ). Patients with an ASA physical status of 5 are often excluded because (by definition) they have a low likelihood of survival and it is difficult to determine whether their arrest is a result of their condition or related to anesthesia. Patients with an ASA classification ≥3 are nine times more likely, and those with an ASA classification of 4 and 5 are 30 to 300 times more likely, to have a perioperative cardiac arrest than those with an ASA classification of 1 or 2 ( ; ; ). Prematurity, congenital heart disease, and other congenital defects are comorbidities that increase the risk for children, especially in the neonatal period ( ; ; ; ).

The designation of emergency status to a patient’s procedure is a risk factor for both perioperative cardiac arrest and mortality. Emergency designation is associated with a 3.5- to 6.8-fold increase of pediatric perioperative cardiac arrest ( ; ). In addition to a higher incidence of arrests, emergency status is related to increased mortality after perioperative cardiac arrest in both children and adults ( ; ; ; ). The patient’s condition, the lack of optimal preoperative preparation and personnel, or both could be the reason for the increased risks of perioperative cardiac arrest and death in emergent procedures.

Etiology of cardiac arrest during anesthesia

Etiologies of cardiac arrest during anesthesia are categorized either by the organ systems involved or by the interventions applied. Table 57.2 shows a summary of the reported etiologies of cardiac arrest and the phase of the anesthetic. The POCA Registry uses a categorization system that involves both interventions and organ systems and reports arrests as medication-related, cardiovascular, respiratory, or equipment-related ( ; ). Some etiologies may be difficult to categorize because they fit into several groups. For example, succinylcholine-induced dysrhythmia can be classified as either a medication-related or a cardiovascular cause of cardiac arrest. A set of guidelines for reporting cardiac arrest data, known as the pediatric Utstein guidelines, suggested an organ system–based classification for etiologies: cardiac, pulmonary, and cardiopulmonary ( ). The Utstein guidelines have not been widely incorporated into the reporting of perioperative cardiac arrest. Typically, the anesthesia literature groups the etiology of cardiac arrest into medication-related, cardiovascular, or respiratory causes, with reports varying the contents within each classification. Box 57.2 shows general categories and etiologies of cardiac arrest during anesthesia.

TABLE 57.2
Etiology and Timing of Pediatric Perioperative Cardiac Arrest
NO. OF CARDIAC ARRESTS ETIOLOGY OF CARDIAC ARREST, n TIMING OF CARDIAC ARREST, %
Author, Year Types of Surgery All, n Anesthesia-related, n Cardiac Respiratory Medication Embolic Hemorrhage Other Induction Maintenance Emergence or Later
All 289 150 * 38 30 55 2 8 17 37% 45% 18%
Noncardiac 8 * 2 3 3 1 1
All 35 * 7 18 5 2 10 71% 29%
Noncardiac 26 * 6 8 5 3 10 7 (27%) 19 (73%)
All 397 193 * 79 53 35 4 23 26 46 (24%) 111 (58%) 36 (19%)
Noncardiac 27 * 9 3 5 1 6 12 33% 67%
All 42 8 29 10 2 =

* Denotes group with results for cardiac arrest etiology

reported the results of cardiac arrest separately for cardiac and noncardiac cases. None of the cardiac arrests during cardiac procedures were considered to be anesthetic related.

classified hemorrhage and embolic etiologies as cardiac.

BOX 57.2
Etiologies of Cardiac Arrest During Anesthesia

Medication-related causes

  • Anesthetic overdose, or relative overdose, of inhalational or intravenous agent

  • Succinylcholine-induced dysrhythmia

  • Neostigmine-induced dysrhythmia

  • Medication “swaps”

  • Drug reactions

  • Unintended intravascular injection of local anesthetic

  • High spinal anesthesia

  • Local anesthesia toxicity

  • Inadequate reversal of a paralytic agent

  • Opioid-induced respiratory depression

Cardiovascular causes

  • Hypovolemia

  • Hemorrhage

  • Inadequate or inappropriate volume administration

  • Hyperkalemia caused by succinylcholine, rapid or large volume transfusion, reperfusion, myopathy, potassium administration, or renal insufficiency

  • Hypocalcemia from citrate intoxication during rapid blood product administration

  • Hypoglycemia

  • Vagal episodes caused by traction, pressure, or insufflation involving the abdomen, eye, neck, or heart

  • Central venous catheter-related dysrhythmia, hemorrhage, or tamponade

  • Anaphylaxis after exposure to latex, contrast agents, drugs, or dextran

  • Embolism of air, clot, or fat

  • Malignant hyperthermia

  • Hypothermia

  • Myocardial ischemia

  • Sepsis

  • Adrenal insufficiency

Respiratory causes

  • Inadequate ventilation and oxygenation

  • Inability to ventilate because of laryngospasm, bronchospasm, airway mass

  • Endotracheal tube misplacement, kink, plug, or inadvertent removal

  • Difficult-to-manage airway anatomy

  • Residual neuromuscular weakness

  • Aspiration

  • Pneumothorax

Medication-related etiologies were historically the most frequent causes of anesthesia-related cardiac arrest in children (approximately 35%; range, 4% to 54%) ( ; ; ; ; ; ; ). Since the late 1990s, medication-related etiologies have decreased (5% to 28%), and cardiovascular and respiratory causes are the most frequently reported ( ; ; ; ). Fig. 57.2 shows the change in perioperative cardiac arrest etiology during the two POCA reports from 1994 to 1997 and 1998 to 2004 ( ). This decrease in medication-related arrests may be the result of reductions in inhalational agent overdoses, dysrhythmias, and myocardial depression that correspond with sevoflurane replacing halothane for inhalational induction. It is not clear if sevoflurane is less cardiotoxic than halothane or if the halothane vaporizer allowed delivery of greater multiples of the minimum alveolar concentration (MAC) of anesthetic than the sevoflurane vaporizer (1 MAC halothane = 0.8% with maximum vaporizer setting 5% versus 1 MAC sevoflurane = 3.3% with maximum vaporizer setting 8%) ( ). Similarly, succinylcholine-induced dysrhythmias during anesthesia decreased when a black box warning regarding the use of succinylcholine in children was issued in the late 1990s. One medication-related cause of anesthesia-related cardiac arrests that continues to be common is the relative anesthetic overdose. A relative anesthetic overdose involves the use of an appropriate dose of an intravenous (IV) or inhaled anesthetic that causes an unexpected hemodynamic effect (usually because of patient morbidity, e.g., sepsis or cardiac disease) and subsequent cardiovascular compromise or collapse requiring resuscitation ( ). Other medication-related causes of anesthesia-related cardiac arrest include syringe swaps (administration of the wrong medication) and the accidental IV administration of local anesthetic intended for the epidural space that results in local anesthetic toxicity. Medication-related causes of cardiac arrest that occur in the PACU usually include the inadequate reversal of muscle relaxant and opioid-induced respiratory depression.

Fig. 57.2, Causes of anesthesia-related cardiac arrest during the period of 1998 to 2004 are compared with causes during the period of 1994 to 1997. Multiple and miscellaneous other causes (3% from 1998–2004 vs. 4% from 1994–1997) not shown. ** p < 0.01, 1998 to 2004 vs. 1994 to 1997 by Z test.

Cardiovascular etiologies cause approximately 40% to 70% of the anesthesia-related cardiac arrests in children ( ; ; ; ; ). Hypovolemia-associated arrests reported in this category include inadequate volume administration, excessive hemorrhage, and inappropriate resuscitation with crystalloid and/or colloid ( ; ; ). The hyperkalemia-associated dysrhythmias reported in this category are caused by succinylcholine administration, rapid transfusion of blood products, reperfusion, myopathy, or renal insufficiency ( ). Vagally induced dysrhythmia or cardiovascular collapse (asystole) can result from procedural traction or pressure (insufflation) exerted on the abdomen, eye, neck, or heart. Anaphylaxis-associated cardiovascular collapse can occur from exposure to a wide variety of common operating room substances (latex, contrast, medications, or dextrans). Patients with underlying cardiac disease are more likely to arrest from a cardiovascular etiology (50%) than are patients without cardiac disease (38%) ( ). Venous air embolism is an important cause of cardiovascular collapse and cardiac arrest in patients under anesthesia. And finally, malignant hyperthermia is an infrequently reported cause of cardiac arrest in this group.

Respiratory etiologies cause approximately 35% (range: 15% to 71%) of anesthesia-related cardiac arrests in children and adults ( ; ; ; ; ; ; ; ; ). Respiratory etiologies of cardiac arrest have declined over the years as a source of malpractice claims, from 51% in the 1970s to 23% by 2000 ( ). This decline may be the result of the increased use of continuous pulse oximetry and quantitative end-tidal carbon dioxide monitoring in the perioperative period. Inadequate oxygenation and ventilation are broad categories often indicated as causes of cardiac arrest in this group. “Loss of the airway” is another broad category and may involve laryngospasm, bronchospasm, an anatomically difficult airway, or an endotracheal tube (ETT) that is misplaced, kinked, plugged, or inadvertently removed. Aspiration is a respiratory cause of anesthesia-related cardiac arrest, but although the aspiration occurs in the operating room, the arrest often occurs much later because of pneumonitis and hypoxia, and this etiology is infrequently reported.

Equipment-related etiologies cause approximately 4% (range, 0% to 20%) of anesthesia-related cardiac arrests in children and adults ( ; ; ). The most common causes of equipment-related cardiac arrest include bleeding or dysrhythmia related to central venous catheter insertion and breathing circuit disconnection. Other, unclassified, causes of anesthesia-related cardiac arrest reported include multiple events (3%) ( ), inadequate vigilance (6%) ( ), and unclear etiology (9%; range, 1% to 18%) ( ).

Determination that a perioperative cardiac arrest is attributable to the anesthetic or anesthesia care is a subjective decision. Variability in the interpretation of these definitions and in methodology makes it difficult to compare and reconcile the rates of anesthesia-related cardiac arrest and death ( ). Patient-related factors, procedure-related factors, and anesthesia care–related factors are the three most important determinants of etiology of intraoperative cardiac arrest. Attempts to determine the extent to which anesthesia care causes an arrest have resulted in the addition of terms such as “anesthesia-associated” and “anesthesia-attributable” cardiac arrest. The relative contribution of patient comorbidities and surgical or procedural factors further complicates this determination. To what extent does the anesthesia care contribute to an arrest caused by surgical bleeding in a coagulopathic patient? Some studies simply use the term anesthesia-related to describe a cardiac arrest that occurs after an anesthesiologist has been involved in the care of the patient.

It is important to know that anesthesia-related cardiac arrests are often preventable and frequently reversable. It is estimated that 53% of anesthesia-related cardiac arrests and 22% of anesthesia-related mortalities are preventable ( ). Human error is an important factor in deaths attributable to anesthesia and usually manifests not as a fundamental ignorance but as a failure to apply existing knowledge ( ). Poor preoperative preparation and inadequate vigilance are frequently reported avoidable errors. Proper preoperative preparation by pediatric anesthesiologists includes the identification of symptoms in patients with an undiagnosed muscular dystrophy, with coronary involvement from William syndrome, with prolonged QT syndrome, or with cardiomyopathy. Adequate vigilance includes early recognition of progressive bradycardia and rapid response to persistent hypotension. A relative anesthetic overdose can be avoided by using a “test dose” or divided dosing when administering medications that may cause hypotension in unstable patients. Transfusion-related hyperkalemia, local anesthetic toxicity, and inhalational anesthetic overdose are other important and preventable etiologies of “anesthesia-related” cardiac arrest ( ).

Non-anesthesia-related cardiac arrest is most often the result of the patient’s underlying condition or the procedure being performed. Trauma, exsanguination, and failure to wean from cardiopulmonary bypass are three of the most often reported causes of non-anesthesia-related cardiac arrest. Myocardial infarction, pulmonary embolus, sepsis, and ruptured aneurysm are other, less frequently observed patient-related causes of cardiac arrest. Procedure-related causes include technical problems, caval compression, vagal asystole related to traction or insufflation, and complications related to transplantation.

In summary, major risk factors for anesthesia-related mortality have been identified and include young age (especially <1 month of age but also <1 year of age), ASA physical status of ≥3, emergent procedures, and cardiac surgery. There is a need for a standardized definition of anesthesia-related cardiac arrest because, without a standard, it will be difficult to determine whether we are making progress in this area. Fortunately, the reporting of etiologies of anesthesia-related cardiac arrest is becoming more congruent, and common causes are recognized. Based on the knowledge of these etiologies, improvements in preparation and vigilance can help prevent or reverse anesthesia-related cardiac arrest.

Outcomes from cardiac arrest during anesthesia

What is the risk of a child dying during the perioperative period? Studies investigating this question report varied results depending on whether they include only “anesthesia-related” or all causes of perioperative cardiac arrest. Although survival is the outcome most commonly considered a measure of successful resuscitation, mortality is the variable most commonly reported in the literature. “Anesthesia-related” mortality during 2000 to 2018 is reported as 0.1 to 1.6 per 10,000 procedures ( ; ; ; ; ; ), which is down from the 2.9 per 10,000 reported between 1947 and 1958. Three studies between 2001 and 2006 reported no anesthetic-related deaths ( ; ; ). When all causes of perioperative cardiac arrest are included (anesthetic, surgical, and patient disease), the risk of mortality is 3.8 to 13.4 per 10,000 procedures in reports from 1990 to 2011 ( ; ; ; ; ). The largest report of pediatric perioperative cardiac arrest, encompassing over 1 million anesthetics from 2010 to 2015, found a mortality of 0.94 per 10,000 procedures ( ).

When reporting survival, there are inconsistencies in the duration of the survival (e.g., to 24 hours, to hospital discharge, to 6 months, etc.) and in the quality of the survival (neurologic status is missing). A patient may “survive” the initial resuscitation attempts but subsequently die in the intensive care unit (ICU) from persistent hemodynamic instability or be left with a devastating neurologic injury. The return of spontaneous circulation (ROSC) is defined as the restoration of a perfusing rhythm and blood pressure that persists for at least 20 minutes post arrest. The rate of ROSC is sometimes reported to indicate successful resuscitations but may not be a meaningful endpoint. The number of patients who achieve ROSC after cardiac arrest is greater than the number who have a longer, more meaningful period of survival. An assessment of the quality of survival should acknowledge whether the patient survives to discharge from the hospital and the presence and severity of a new neurologic deficit.

The overall survival rate from pediatric perioperative arrest is reported between 46% and 92% ( ; ; ; ; ; ; ; ). The later studies report better survival rates of 72% to 92% ( ; ; ; ). Two studies report ROSC and survival individually. A report of 27 cardiac arrests in 2008 found 85% had ROSC and 46% survival to hospital discharge ( ). A report of 42 cardiac arrests in 2016 found 95% had ROSC and 85% survival to discharge ( ). Reports of long-term sequelae from pediatric perioperative cardiac arrest are limited. A 2007 report from the POCA data found 61% of children had no neurologic injury after anesthesia-related cardiac arrest ( ). A 2016 review of 72 anesthesia-related cardiac arrests reported no sequelae in 88% ( ). As rates of ROSC and survival from perioperative cardiac arrest improve, hopefully, authors will include more detailed, long-term functional status of these patients.

Increases in survival from perioperative cardiac arrest have paralleled improvements in outcomes of “in-hospital” cardiac arrest (IHCA) in children. A 2019 report of survival to hospital discharge of pediatric IHCA (inclusive of both perioperative and nonperioperative cardiac arrest) was 32% for pulseless arrest and 63% for nonpulseless events. Additionally, survival from both pulseless and nonpulseless cardiopulmonary resuscitation (CPR) events significantly increased over the time of the study ( ). This is an increase from previous reports of pediatric IHCA survival to discharge of 8% to 42% ( ; ; ; ; ). The survival rates for children after a perioperative cardiac arrest, 72% to 92%, are higher than for IHCA, 32% to 63%. Potential explanations for a higher resuscitation rate from perioperative cardiac arrest include the resuscitation skills and training of the anesthesiologist, advanced preparation for emergencies, reversible causes of anesthesia-related cardiac arrest, and continuous hemodynamic and respiratory monitoring during anesthesia that provides early recognition of problems.

Several factors affect the likelihood of successful resuscitation and survival. Mortality is increased if the etiology of the cardiac arrest is hemorrhage or is associated with protracted hypotension ( ; ). Perioperative cardiac arrest occurring during nights or weekends has a doubling of mortality ( ). Patient comorbidities, as indicated by the ASA or emergency status, increase the risk of mortality from perioperative cardiac arrest ( ; ; ). Patients with underlying cardiac disease have a higher mortality rate after cardiac arrest than patients without (33% vs. 23%) ( ). The highest mortality is in cardiac patients with aortic stenosis, cardiomyopathy, and single-ventricle physiology prior to superior cavopulmonary anastomosis. These three groups accounted for over 75% of the deaths reported in children with congenital or acquired heart disease. In addition, more than half of patients with heart disease arrested in the general operating room (54%) as opposed to the cardiac operating room (26%) or cardiac catheterization laboratory (17%). Finally, factors related to CPR can affect outcome; these include the presenting cardiac rhythm, duration of resuscitation, and duration of “no-flow” and “low-flow” states during arrest and resuscitation.

In summary, the incidence of pediatric perioperative cardiac arrest is decreasing. The understanding of risk factors for both perioperative arrest and outcome has improved. Still needed are better definitions and more uniform reporting of survival parameters and the exploration of long-term outcomes beyond survival.

Cardiopulmonary resuscitation

Recognizing the need for cardiopulmonary resuscitation

The primary goals of CPR are to minimize the no-flow time associated with cardiac arrest and maximize oxygen delivery to vital organs during the low-flow period of resuscitation. The potential for injury from low-flow or no-flow intervals can be reduced by the early recognition that a child’s vital signs are inadequate and the rapid initiation of quality CPR. It is difficult to give guidelines for the limit of each vital sign at which vital organ blood perfusion becomes inadequate for every child under anesthesia ( Table 57.3 ). These limits depend on many factors that include the patient’s general health and age, the type and depth of anesthetic, and the intensity and duration of vital sign decompensation. Ensuring adequate end-organ perfusion requires an understanding of the metabolic supply and demand of the vital organs in children of various ages and development. Advanced pediatric training and experience are valuable in these infrequent but critical situations to help practitioners recognize the threat of injury and rapidly initiate CPR.

TABLE 57.3
Adequate Vital Signs for Children
Modified from AHA/ILCOR Guidelines, Part 14: Pediatric Advanced Life Support. Circulation, 122 (Suppl 3), S876-908, 2010, AAP AHA Pediatric Advanced Life Support Provider Manual, 2010 and the JHH Harriet Lane Handbook, 17th edition.
HEART RATE (BEATS/MINUTE) * BLOOD PRESSURE
Age Bradycardia Normal PALS/HLH Tachycardia Hypotension
Term neonate <60 80–205
95–180
>220 SBP <60
Infant <60 75–190
110–180
>190 SBP <70
Child <60 60–140
60–150
>180 SBP <70 + (2 × age in years)
>10 yr <60 50–100
60–100
>150 SBP <90
HLH, Heart rate range from 2005 Harriet Lane Handbook; PALS, heart rate range from the 2010 Pediatric Advanced Life Support provider manual; SBP, systolic blood pressure.

* Bradycardia is the rate at which chest compressions should be considered. Note that normal for >10 years may be below the level recommended, and signs of inadequate perfusion should be assessed. Tachycardia listings are estimated rates at which symptoms usually occur.

CPR, including chest compressions, should be initiated when the anesthesia provider believes that perfusion is inadequate to deliver oxygen, substrates, or resuscitative medications to the heart or brain. The extensive intraoperative monitoring and continuous presence of anesthetic personnel are optimal for early detection of inadequate perfusion or ventilation in the operating room. In the absence of adequate monitoring, healthcare personnel can detect an abnormal heart rate or pulse quality by palpating the umbilical artery in the newly born, the brachial artery in the infant, and the carotid artery in the child. The analysis of anesthetized and slightly hypotensive (systolic pressure <70 mm Hg) infants revealed that detection of a pulse within 10 seconds was best with auscultation; the success of detection of a pulse using femoral, brachial, or carotid palpation varied with the training of the provider ( ; ). A reliable pulse cannot usually be detected when the systolic pressure is <50 mm Hg.

In the operating room, monitoring is readily available to help determine vital signs of an anesthetized child. When the monitoring is unavailable or the readings are in question, having one rescuer auscultate and another palpate may increase reliability and decrease the time needed to count a heart rate and determine the palpability of a pulse. The administration of anesthesia interferes with the utility of typical indicators for chest compressions such as unresponsiveness or apnea. Significant bradycardia by auscultation or lack of pulse by palpation may be valid indicators to start CPR in the operating room.

Physiology of cardiopulmonary resuscitation: Reestablishment of ventilation

The fraction of inspired oxygen that should be administered during CPR

The fraction of inspired oxygen (Fi o 2 ) that should be administered during CPR is important because either too much or too little may be detrimental. In 1954 Elam showed that exhaled air from the rescuer (16% oxygen) provides adequate oxygenation of the victim (oxygen saturation [Sa o 2 ] of 90% or greater) and became the basis for ventilation during CPR when supplemental oxygen is not available ( ). In the operating room, the anesthesiologist can normally administer 100% oxygen via tracheal intubation during CPR. The anesthesiologist is faced with the theoretical concern that the delivery of high levels of oxygen during reperfusion may increase formation of oxygen free radicals and increase cellular injury. This theoretical concern is weighed against the knowledge that CPR represents a low-flow state, that chest compressions are less effective in restoring oxygen delivery to the brain and heart than native circulation, and that during CPR providing low oxygen levels may delay the restoration of oxygen delivery. Adequacy of oxygen delivery during CPR depends on many variables, including cause of arrest, duration of decreased perfusion, effectiveness of chest compressions, and the patient’s metabolic demands. The complexity of these determinations makes it unlikely that oxygen delivery during CPR can be measured or predicted. A review of newborn resuscitation using 21% or 100% Fi o 2 found that (1) “depressed” (not arrested) newborns can be resuscitated effectively with either 21% or 100% oxygen and that 21% oxygen administration is associated with fewer markers of oxidative stress and (2) for newborn cardiac arrest, there is no evidence that 21% oxygen is as effective as 100% oxygen in resuscitation of circulation, and animal studies suggest that 100% oxygen is more effective ( ). A piglet model of brain tissue oxygen monitoring during CPR for cardiac arrest showed that despite administration of 100% Fi o 2 , the brain tissue oxygen levels remained at or below prearrest levels until after ROSC, when they became dramatically elevated ( ). This finding implies that maximal oxygen administration is needed during CPR but can create hyperoxic conditions during reperfusion after ROSC. Without adequate data to resolve this question, it is reasonable to administer 100% Fi o 2 during CPR for intraoperative arrest to maximize oxygen delivery during this low-flow state and subsequently reduce oxygen levels when monitoring shows adequate oxygenation after ROSC (see Postresuscitation Care). American Heart Association (AHA) guidelines still suggest the use of 100% oxygen when initiating basic life support (BLS) and advanced life support (ALS) resuscitations for this reason ( ; ). Titration of Fi o 2 after ROSC is generally aimed at pulse oximetry levels of 94% to 99% ( ). The exception to the use of 100% Fi o 2 for resuscitation may be the child with a parallel circulation, such as a hypoplastic left heart or other single-ventricle physiology, whose poor systemic perfusion may be the result of a low pulmonary vascular resistance in relation to the systemic vascular resistance. The administration of 100% Fi o 2 in this situation may worsen the systemic perfusion. In such a case, the anesthesiologist will need to decide whether high levels of oxygen administration will contribute to the poor systemic circulation.

The contribution of chest compressions to ventilation during CPR

The contribution of chest compressions to ventilation during CPR can influence the decision of how much ventilation to provide to victims of cardiac arrest. Early in the study of external compressions, researchers did not add ventilation during CPR because they believed that closed-chest compression alone provided adequate ventilation ( ). The findings that chest compressions result in some ventilation for adult victims and that minimal, early ventilation is necessary after a sudden fibrillatory arrest has resulted in interest in “compressions-alone” CPR. Determining the adequacy of chest compression contribution to ventilation is difficult in the pediatric population and may vary with the arrest etiology, arrest duration, child’s age, airway patency, underlying medical condition, chest compression efficacy, and child’s metabolic needs. Requirements to administer oxygen and remove carbon dioxide (CO 2 ) will differ by type of arrest. Patients who experience a sudden fibrillatory arrest will have little loss of oxygen reserve or accumulation of CO 2 , whereas those who undergo a gradual asphyxial arrest will have a greatly depleted oxygen reserve and a large accumulation of CO 2 . Patients with asphyxial arrest derive a greater benefit from ventilation efforts. A piglet model of asphyxial arrest shows more benefit with delivery of both compressions and ventilations than with compression or ventilation alone ( ). Provision of ventilation early during resuscitation for cardiac arrest may be less necessary and has the potential to cause a respiratory alkalosis that could cause unwanted effects on brain circulation and oxygen delivery. As arrest duration continues, despite quality CPR efforts, metabolic acidosis will predominate, and respiratory compensation may be difficult with compressions-alone CPR. It is reasonable for the pediatric anesthesiologist to initially choose a ventilation rate based on recommendations for age (20 to 30 ventilations per minute) and to subsequently adjust if blood gas analysis becomes available during resuscitation ( Table 57.4 ) or after ROSC.

TABLE 57.4
Intraoperative Basic Life Support Procedures
Adapted from Aziz, K., Lee, H. C., Escobedo, M. B., et al. (2020). Part 5: Neonatal resuscitation: 2020 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation , 142 (16, Suppl. 2), S524-S550; Topjian, A. A., Raymond, T. T., Atkins, D., et al., on behalf of the Pediatric Basic and Advanced Life Support Collaborators. (2020). Part 4: Pediatric basic and advanced life support: 2020 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation, 142 (Suppl. 2), S469-S523.
Newborn Infant ( < 1 yr) Child (1 yr to puberty) Adolescent ( > puberty)
Breaths, intubated 30/min 20–30/min 20–30/min 12–20/min
Pulse check Difficult, use ECG for heart rate, Umbilical/brachial Brachial/femoral Carotid/femoral Carotid/femoral
Compression landmark Lower third of sternum Lower third of sternum Lower third of sternum Lower half of sternum
Compress using 2 thumbs encircling 2 thumbs encircling 1 or 2 hands 2 hands
Compression depth One-third chest AP diameter One-third AP diameter, (4 cm) One-third AP diameter (5 cm) 5–6 cm
Compression rate (Intubated patient) 90/min 100–120/min 100–120/min 100–120/min

Intubation of the trachea during CPR

Intubation of the trachea by the anesthesiologist is recommended for the management of ventilation during intraoperative cardiac arrest. Without intubation and positive-pressure ventilation, soft tissue obstruction prevents adequate ventilation in some victims. There may be a benefit of a small amount of positive end-expiratory pressure during CPR to prevent “intrathoracic airway collapse,” loss of functional residual capacity, and maintenance of compression-assisted ventilation. This constant pressure may be more reliably produced with an ETT in place ( ). The loss of protective airway reflexes and the likelihood of stomach distension with positive-pressure ventilation increase the risk for aspiration during CPR in unintubated patients ( ). At the onset of cardiac arrest, the competency of the lower esophageal sphincter decreases from approximately 20 cm H 2 O to 5 cm H 2 O and can predispose to stomach ventilation at low inspiratory pressures ( ). The laryngeal mask airway (LMA) compares favorably to mouth-to-mouth, mask ventilation, and other airway adjuncts during CPR. Limited data are available for a comparison of LMA with tracheal intubation during CPR, and these other methods may be less protective of gastric distension or aspiration than tracheal intubation. Studies of in-hospital and out-of-hospital arrests indicate worse survival to discharge when advanced airways are attempted ( ; ). However, airway adjuncts are not recommended as a replacement for tracheal intubation during perioperative CPR in children, when an anesthesiologist is available ( ). Training allows the anesthesiologist to obtain rapid placement of an ETT with minimal to no interruptions in chest compressions. If trained anesthesia personnel are unavailable or the patient has a contraindication to rapid placement of an ETT (i.e., a difficult airway), then care providers may elect to forego placement of an ETT and continue resuscitation with an unsecured airway. Therefore it is up to the practitioner to weigh the risk and benefits of ETT intubation for each patient.

The appropriate placement of the ETT during cardiac arrest can be verified in most instances by the presence of end-tidal CO 2 (ETCO 2 ). Capnography is more useful during CPR compared with colorimetric ETCO 2 measurement and is readily available in the perioperative area, making it the monitor of choice for ETT placement and monitoring. The incidence of an ETT being accidentally placed in the esophagus of a child is greater during an arrest (19% to 26%) than during a nonarrest intubation (3%) ( ; ). Demonstration of persistent (>6 ventilations) ETCO 2 after intubation is reliable for confirming correct placement of the ETT in children with spontaneous circulation ( ). A lack of measurable ETCO 2 level in the ETT usually indicates esophageal intubation. During resuscitation for cardiac arrest, the pulmonary blood flow is decreased during CPR, and the ETCO 2 level may be falsely low or absent despite a correctly placed ETT. This finding of no ETCO 2 detected during CPR in arrested children occurs in 14% to 15% of correctly placed ETTs ( ; ). Continually detectable ETCO 2 is proof of tracheal intubation even during arrest. The absence of ETCO 2 at ETT placement during resuscitation should prompt visual inspection by direct laryngoscopy to discriminate esophageal intubation. Laryngoscopy may be done without interruption of chest compressions. Subsequent loss of ETCO 2 during resuscitation efforts may indicate that the ETT is dislodged and should be reinspected or replaced, that the ETT is plugged or kinked and a suction catheter should be passed, or that pulmonary blood flow is diminished and resuscitation efforts need to be increased. Tracheal intubation for resuscitation also offers the option of access (although limited) to the circulation for drug administration (see Intratracheal Medication Administration ).

Interruption of chest compressions for delivery of interposed ventilations increases the percentage of time that vital organs are not perfused. This percentage of CPR efforts without perfusion is referred to as the no-flow fraction (NFF). In addition to producing periods of no perfusion, interruptions in the delivery of compressions result in a pooling of blood in the vasculature that requires several compressions before perfusion returns to the preinterruption level ( ). Thus interrupting compressions to deliver ventilations causes both no-flow and low-flow intervals that can be avoided by placement of an ETT. An overarching goal of all resuscitations is to minimize interruptions regardless of reason ( ). During bystander CPR, compressions are held when ventilations are delivered and then compressions are resumed. These pauses in chest compressions for interposed ventilation provided during mouth-to-mouth or bag-mask ventilation improve delivery of ventilation to the lungs and reduce the probability of gastric inflation.

A substantial amount of research has compared the effects of chest compression:ventilation ratios of 15:2, 30:2, and longer (continuous compressions) with varying results for fibrillatory and asphyxial cardiac arrest in prehospital settings ( ; ). Placement of an ETT eliminates the need to interpose ventilations and allows compressions to be performed without interruptions. The goal for the anesthesiologist is to maintain continuous delivery of compressions, with only a brief (<10-second) interruption at 2-minute intervals to switch compressors (to prevent fatigue), to check pulse and rhythm, to determine ROSC, and to deliver shocks if needed. Intubation, central line placement, and placement of adhesive pads for defibrillation are other commonly reported interruptions to chest compressions and should be minimized; alternatively, compressions should be continued during these events when possible. It is important to remember the negative impact on survival of pausing compressions during intubation attempts and absolutely minimize the duration of procedures that require these interruptions ( ).

The effect of positive-pressure ventilation on perfusion produced by chest compressions

It is important to understand the effect of positive-pressure ventilation on perfusion produced by chest compression. In the previous section, we discussed the importance of minimizing the NFF by maintaining compressions and not interrupting for ventilations. However, ventilation has other physiologic interactions on chest compression effectiveness. These interactions include the impact of increased intrathoracic pressure on the effectiveness of chest compression to push blood out of the thorax, the potential to increase intracranial pressure (ICP) and reduce perfusion of the brain, the effect on myocardial perfusion pressure (MPP), and the effect on venous return to the thorax.

Various methods of ventilation delivery (independent of being interposed between compressions or synchronized with compression) allow both adequate oxygenation and ventilation, but their effects on hemodynamic pressures vary. Simultaneous compression and ventilation CPR (SCV-CPR) increases intrathoracic pressure at the time of compression and improved survival in a canine model but not in a human trial. The simultaneous increase in intrathoracic pressure may increase ejection of blood from the thorax, but elevation of intrathoracic pressure also increases intracardiac and intracranial pressures. The increase in intracardiac pressure at the time of compression may prevent increases in the MPP and provide no overall benefit to the heart. The ICP may increase with the increase in intrathoracic pressure during ventilation (see the section on compression physiology that follows for the mechanism) and may produce no improvement in the cerebral perfusion pressure and no benefit to the brain. Increasing intrathoracic pressure during the relaxation phase of chest compressions has the potential to decrease venous return and may have a significant impact on the effectiveness of subsequent compressions, depending on the duration of ventilation pressure. However, application of some positive end-expiratory pressure may prevent intrathoracic airway collapse (loss of functional residual capacity), prevent decreased pulmonary blood flow, and augment effectiveness of compressions and ventilation ( ). Attention to the rate, duration, and inspiratory and expiratory pressures applied during the delivery of ventilations can prevent excessive ventilation (frequent during the high stress of resuscitation) and its negative impact on venous return.

Overventilation or underventilation can be detrimental during CPR. As discussed earlier, overventilation can have hemodynamic effects or result in hypocarbia (usually postresuscitation), causing decreased perfusion of the brain. Underventilation could decrease perfusion to vital organs, either from reduced pulmonic blood flow during CPR (secondary to the increased pulmonary vascular resistance that results from atelectasis) or from the contribution of respiratory acidosis to the ongoing systemic metabolic acidosis. Determination of a ventilation rate during CPR will depend on the age of the child, whether the airway is secured, the number of rescuers, the type of arrest, and the duration of arrest. The young child has high baseline metabolic activity and needs more ventilations during CPR than an older child. Higher rates of ventilation than recommended in the past have been associated with better outcomes ( ). Recommendations for newborns include rates of approximately 30 breaths per minute, regardless of whether one or two rescuers are present and whether the newborn is intubated. Infants, children (1 year to puberty), and adolescents share a recommendation for ventilation with 20 to 30 breaths per minute during CPR when intubated (see Table 57.4 ) ( ). The newborn has the highest metabolic activity and baseline CO 2 production and a greater chance of having an arrest with a prolonged asphyxia period; therefore the need to eliminate CO 2 is greater. The decrease in pulmonary blood flow during CPR for cardiac arrest results in increased levels of venous CO 2 (PvCO 2 ) and decreased levels of arterial CO 2 (Pa co 2 ) and ETCO 2 . Determining the adequacy of ventilation efforts during CPR is difficult because low pulmonary blood flow results in increased physiologic dead space and affects the CO 2 levels of both ETCO 2 and blood gas monitoring. These techniques regain their usefulness in monitoring ventilation efforts as pulmonary blood is improved with resuscitation or ROSC.

The use of mechanical or manual ventilation during CPR

In addition to deciding how much ventilation to provide, the anesthesiologist needs to decide whether to use mechanical or manual ventilation during CPR for intraoperative arrest. This decision may be based on the airway management strategy, lung compliance, and presence of other experienced providers. No difference in hemodynamics was seen when comparing mechanical with manual ventilation during CPR in a porcine model ( ). The use of pressure-controlled mechanical ventilation at prearrest settings provided appropriate blood gases during CPR in piglets ( ). It is probable that the use of chest compression when using pressure-controlled ventilation reduces delivered tidal volumes and matches ventilation to the reduced pulmonary blood flow that occurs during CPR.

Physiology of cardiopulmonary resuscitation: Reestablishment of circulation

Mechanisms of blood flow during cardiopulmonary resuscitation

proposed that external chest compressions squeeze the heart between the sternum and the vertebral column, forcing blood to eject. This assumption of direct cardiac compression by external chest compressions became known as the cardiac pump mechanism of blood flow during CPR. The cardiac pump mechanism proposes that the atrioventricular (AV) valves close during ventricular compression and that ventricular volume decreases during ejection of blood. During chest relaxation, ventricular pressures fall below atrial pressures, enabling the AV valves to open and the ventricles to fill. This sequence of events resembles the normal cardiac cycle and occurs with use of direct cardiac compression during open-chest CPR.

Several observations of hemodynamics during external chest compressions are inconsistent with the cardiac pump mechanism for blood flow ( Table 57.5 ). First, similar elevations in arterial and venous intrathoracic pressures during closed-chest CPR suggest a generalized increase in intrathoracic pressure. Second, reconstructing thoracic integrity of patients with flail sternums improves blood pressure during chest compressions (which is unexpected, because a flail sternum should allow more direct cardiac compression during closed-chest CPR). Third, patients who develop ventricular fibrillation produce enough blood flow by repetitive coughing or deep breathing to maintain consciousness; these are situations in which no direct cardiac compression occurs but only an increase in intrathoracic pressure. These observations suggest that changes in intrathoracic pressure contribute to the production of blood flow during chest compressions. The finding that changes in intrathoracic pressure without direct cardiac compression (i.e., a cough) produce blood flow epitomizes the thoracic pump mechanism of blood flow during chest compressions. Familiarity with the thoracic pump and cardiac pump mechanisms of blood flow during CPR contributes to an understanding of how continuous monitoring of CPR effectiveness may be important in patients with changing blood flow mechanisms.

TABLE 57.5
Comparison of Mechanisms of Blood Flow During Closed Chest Compressions
Cardiac Pump Thoracic Pump
Proposed mechanism Sternum and spine compress heart General increase in intrathoracic pressure
Findings during compression
Atrioventricular valves Close Stay open
Aortic diameter Increases Decreases
Blood movement Left ventricle to aorta Pulmonary veins to aorta
Ventricular volume Decreases Little change
Compression rate Dependent Little effect
Duty cycle Little effect Dependent
Compression force Increases role Decreases role
Patient physiology Small chest, high compliance Large chest, low compliance

Thoracic pump mechanism

Chest compression during CPR generates almost equal pressures in the left ventricle, aorta, right atrium, pulmonary artery, airway, and esophagus. Because all intrathoracic vascular pressures are equal, the suprathoracic arterial pressures must be greater than the suprathoracic venous pressures for a cerebral perfusion gradient to exist. Venous valves, either functional or anatomic, prevent direct transmission of the rise in intrathoracic pressure to the suprathoracic veins. This unequal transmission of intrathoracic pressure (through arteries but less so in veins) to the suprathoracic vasculature establishes the gradient necessary for cerebral blood flow during closed-chest CPR.

During normal cardiac activity, the lowest venous pressure measurement occurs on the atrial side of the AV valves, providing a downstream effect that allows venous return to the cardiac pump. The extrathoracic shift of this low-pressure area to the cephalic side of jugular venous valves during the thoracic pump mechanism of CPR implies that the heart is merely serving as part of a conduit for blood flow. Angiographic studies show that during a single chest compression, blood passes from the vena cavae, through the right heart, to the pulmonary artery and from the pulmonary veins, through the left heart, to the aorta. Unlike normal cardiac activity and open-chest CPR, echocardiographic studies during closed-chest CPR have shown that AV valves remain open during blood ejection and aortic diameter decreases rather than increases during blood ejection. These findings during closed-chest CPR support the thoracic pump theory in which the chest becomes the “bellows” to produce blood flow during CPR and that the heart is a passive conduit.

Cardiac pump mechanism

Despite evidence for the importance of the thoracic pump mechanism of blood flow during external chest compressions, there are specific situations in which the cardiac pump mechanism predominates. First, applying more force during chest compressions increases the likelihood of direct cardiac compression and closure of AV valves. Second, a small chest size allows more direct cardiac compression and better hemodynamics during closed-chest CPR. Third, the very compliant infant chest wall should permit more direct cardiac compression, as shown in an infant closed-chest CPR model in which the blood flows produced are superior to those of adult models. Transesophageal echocardiography studies have demonstrated the closing of AV valves during the compression phase of CPR in humans. These findings support the occurrence of cardiac compression during conventional CPR and suggest that both mechanisms of blood flow may occur. As will be seen later, varying the method of chest compressions may alter the contribution of each mechanism.

Efficacy of blood flow during CPR

The level of blood flow to vital organs produced by conventional closed-chest CPR without pharmacologic support (BLS models) is disappointingly low. The range of cerebral blood flow in animal models during CPR is 3% to 14% of prearrest levels. Cerebral perfusion pressures are also low, at 4% to 24% of prearrest levels in animals and only 21 mm Hg in humans ( ). Myocardial blood flows in this basic CPR mode are also discouragingly low at 1% to 15% of prearrest levels in animal models. In preclinical models, MPP (measured in mm Hg) correlates with myocardial blood flow (measured in mL/min/100 g brain tissue) in a one-to-one relationship. Several factors affect cerebral and myocardial blood flow during CPR, and these disappointingly low levels during BLS can be improved with the addition of pharmacologic support.

Physiologic thresholds for minimal vital organ blood flow during CPR have been described. The inability to maintain blood flow above these thresholds during CPR results in organ malfunction. A myocardial blood flow of 20 mL/min/100 g or greater is necessary for successful defibrillation. A cerebral blood flow of greater than 15 to 20 mL/min/100 g is necessary to maintain normal electrical activity during CPR. Models of BLS often do not achieve these thresholds; the addition of ALS measures, such as the administration of epinephrine, is associated with increases in blood flow to levels above these thresholds. The importance of early administration of epinephrine has been shown in several studies of pediatric in-hospital and out-of-hospital cardiac arrest, and current recommendations are for initial epinephrine administration within 5 minutes in any setting ( ).

Maintenance of circulation

The goal of CPR is to minimize the no-flow or low-flow state by restoring and maintaining the best flow possible to the brain and heart until adequate spontaneous circulation is restored. Factors related to the patient, the ventilation technique, and the compression technique will contribute to restoration and maintenance of blood flow during CPR. The pediatric anesthesiologist needs to understand how these factors affect restoration and maintenance of blood flow during an intraoperative arrest.

Patient-related factors

Patient-related factors that influence the effectiveness of CPR to maintain circulation include the patient’s age, duration of CPR, duration of pre-resuscitation ischemia, ICP, and overall volume status.

Based on limited data, young age appears related to higher cerebral blood flow during closed-chest CPR. A piglet model has substantially higher cerebral blood flows (50% of prearrest) and slightly higher myocardial flows (17% of prearrest) than those reported for adult models. Studies on slightly older pigs show higher cerebral blood flow than that in adult models during closed-chest CPR and myocardial flows not different from adult models. No human data exist regarding blood flows at different ages during CPR.

Age-related physical factors that affect the blood flow produced during CPR include chest wall dimensions, chest wall compliance, and chest wall deformability. Chest wall size determines what percentage of the chest surface area is compressed during CPR. A smaller chest wall in relationship to the compressor’s hands or thumbs may contribute to more compression of cardiac muscle mass. More of the ventricular and atrial structures are compressed during CPR in a smaller patient, thereby creating a mechanism of blood flow like the cardiac pump model. Chest wall compliance affects the ability to produce anteroposterior displacement and the ability to directly compress the heart. Younger children have greater chest wall compliance that facilitates adequate compression depth and increases the chance of direct cardiac compression, either of which can result in better blood flow production by chest compressions. These benefits of the compliant infant chest may account for high flows that resemble those produced by open-chest cardiac massage. Chest wall deformability is another factor that affects the ability to maintain flows during prolonged periods of chest compressions. Chest deformation occurs as CPR becomes prolonged. The chest assumes a flatter shape as compressions continue, producing larger decreases in cross-sectional area at the same displacement. Progressive deformation may be beneficial if it leads to more direct cardiac compression. Unfortunately, too much deformation may result in loss of chest wall recoil during release of compression. Decreased chest wall recoil with progressive deformation will limit displacement and produce atelectasis that results in less effective compression, increased pulmonary vascular resistance, and less venous return during release of compression. Increased chest wall deformity and increased chest wall compliance may make children more dependent than adults on direct cardiac compression.

In animal models of conventional CPR, the effectiveness of prolonged chest compressions to produce blood flow progressively decreases. The permanent deformation of the chest approaches 30% of the original anteroposterior diameter. An attempt to limit deformation by increasing intrathoracic pressure during compression with simultaneous compression and ventilation CPR improved neither the amount of deformation nor the time to deterioration of flow. An infant animal model of CPR with a vest to deliver compressions failed to prevent deterioration of blood flow as CPR duration increased. The vest distributes compression force diffusely around the thorax and greatly decreases permanent deformation (3% versus 30%). An echocardiographic study demonstrated how the duration of CPR affects the mechanism of blood flow. Whereas the cardiac pump model predominates early during CPR, this mechanism fades and the thoracic pump model produces a larger component of blood flow ( ). This changing of blood flow patterns with duration of CPR may be more pronounced in children who have more compliant chest walls.

Both the length of no-flow before the initiation of CPR and the duration of CPR have a negative effect on cerebral blood flow that seems to be most detrimental in the infant model. The supratentorial cerebral blood flow during CPR is reduced more than brainstem flow as the preceding ischemic interval is increased. The cause of these detrimental effects on cerebral blood flow is unclear. Tissue hypoxia results in a loss of vascular tone that eventually becomes unresponsive to vasoconstrictors; pulmonary edema, capillary leak, and (with prolonged duration of CPR) chest wall deformity are factors that are likely to contribute. It remains obvious that a short ischemic period and quick resuscitation improve eventual outcome.

ICP is another patient-related factor that affects the circulation produced during chest compressions. ICP can represent the downstream pressure for cerebral blood flow and, if elevated, can inhibit cerebral perfusion. Increases in intrathoracic pressure with external chest compression cause ICP increases. This relationship is linear, and one-third of the increase in intrathoracic pressure generated by chest compression is transmitted to the ICP. The carotid arteries and jugular veins do not appear to be involved in the transmission of intrathoracic pressure to the intracranial contents. The transmission can be partially blocked by occluding cerebrospinal fluid or vertebral vein flow. The rise in ICP with chest compressions becomes more significant when baseline ICP is increased (decreased intracranial compliance) and transmission of intrathoracic pressure to ICP increases from one-third to two-thirds. Thus the efficacy of external chest compressions to perfuse the brain deteriorates markedly when ICP is elevated. When increased ICP is suspected (i.e., child with hydrocephalus or head trauma), care providers should lower the ICP early in the resuscitation (i.e., shunt tapped, hematoma drained) to increase effectiveness of chest compressions to perfuse the brain. Evidence concerning whether a “heads-up” position during CPR decreases ICP and improves cerebral perfusion pressure is conflicting ( ; ). ICP elevation is common in an arrest situation involving a child with a ventricular peritoneal shunt malfunction.

Volume status (more specifically, hypovolemia) is another patient-related factor that can influence the effectiveness of chest compressions. If the patient is severely hypovolemic, it is likely that chest compressions will be less effective. Sparse data address the impact of volume status on blood flow during chest compression. Animal models include reports that fluid administration (30 mL/kg or to a right atrial pressure of 6 to 8 mm Hg) before cardiac arrest induction in fasted animals improves CPR effectiveness. This may be important for fasted patients or situations involving blood loss in the perioperative arena, and therefore volume supplementation may be considered.

Ventilation-related factors

Ventilation-related factors that affect compression-related blood flow during CPR (the need for intubation of the trachea, avoiding interruptions of compressions to deliver ventilations, the effect of ventilation rate, the effect of ventilation pressure, and the decision to ventilate mechanically or manually) are discussed in the preceding section on the reestablishment of ventilation during CPR.

Compression-related factors

Factors related to chest compression that affect blood flow during CPR include compression rate (including NFF and number of compressions delivered), compression duty cycle (the ratio of compression to relaxation), compression force, compression depth, and opportunity for full recoil (avoiding application of pressure during relaxation/leaning).

Compression rate and duty cycle

Compression rate is the number of cycles per minute. Duty cycle is the ratio of compression phase duration to entire compression-relaxation cycle expressed as a percentage. For example, at the recommended rate of 100 compressions per minute (60 seconds), the total cycle for compression and relaxation is 0.6 second (60 sec/100 compressions = total cycle of 0.6 sec/compression). A 0.36-second compression time produces a 60% duty cycle (0.36 sec / 0.6 sec = 60%). The impact of duty cycle differs between the two mechanisms of blood flow described in the previous section (see Table 57.5 ). In 1986 the AHA Guidelines for CPR and Emergency Cardiac Care recommended increasing the rate of chest compressions from 60 to 100 per minute. This change represented a compromise between advocates of the thoracic pump mechanism and those of the cardiac pump mechanism. The mechanics of these two theories of blood flow differ, but a faster compression rate could augment both. It is likely that, in the same patient, both models exist and there is a dynamic balance.

In the cardiac pump mechanism of blood flow during CPR, direct cardiac compression generates blood flow, and the force of compression determines the stroke volume per compression. Prolonging the compression (increasing the duty cycle) beyond the time necessary for full ventricular ejection fails to produce any additional increase in stroke volume in this model. Increases in the rate of compressions increase cardiac output in this model because a fixed ventricular blood volume (stroke volume) ejects with each cardiac compression. Blood flow in the cardiac pump mechanism is thought to be rate-sensitive and duty cycle–insensitive. In the thoracic pump mechanism, the reservoir of blood to be ejected is the large capacity of the intrathoracic vasculature. With the thoracic pump mechanism, increasing either force of compression or duty cycle enhances flow by emptying more of the large intrathoracic capacity. Changes in compression rate have less effect on flow over a wide range of rates in the thoracic pump model. Blood flow in the thoracic pump mechanism is generally duty cycle–sensitive but rate-insensitive. With increases in duty cycle, the percentage of time in compression is prolonged, but time for relaxation decreases and venous return may become inhibited. At slow compression rates, the ability to hold a compression to prolong the duty cycle becomes physically demanding. The increased ability of a rescuer to produce a 50% duty cycle at a rate of 100 (compared with 60) compressions per minute is the reason behind the compression rate change recommendation in the 1986 AHA guidelines for CPR.

The NFF and measurement of compressions delivered ( chest-compression fraction —the inverse of the NFF) are important factors in the continued recommendation of 100 compressions per minute. The NFF is the percentage of time that compressions are interrupted. The interruption of compressions not only produces a no-flow time but also reduces the effectiveness of the initial compressions upon the resumption of chest compressions ( ). This “re-recruitment period” is one of the main reasons to minimize chest compression interruptions. The NFF in bystander CPR for out-of-hospital cardiac arrest (OHCA) has been reported to be 48% ( ). For IHCA, an NFF of 24% has been reported with a sensing monitor/defibrillator ( ). Reducing the pauses for ventilations from a 15:2 to 30:2 compression:ventilation ratio in a bystander model of manikin CPR reduced the NFF from 33% to 22% ( ). Tracheal intubation in OHCA resulted in a reduction of NFF from 61% to 41% ( p = 0.001) ( ).

The preshock pause is another factor that contributes to the NFF. Automatic external defibrillators (AEDs) create a variable preshock pause of 5 to 28 seconds as the software runs through the menu of rhythm disturbances. A 5-second increase in preshock pause was associated with a decrease in shock success ( p = 0.02). Shock success fell from 94% if the pause was <10 seconds to only 38% if it was >30 seconds ( ). Compression interruptions for delivery of ventilation and for AED analysis can be eliminated by intubating and using a manual defibrillator. These are two advantages that are available and appropriate in the operating room. The goal is to have <10 seconds of interruption (to change the compressor and analyze the electrocardiogram [ECG]) every 2 minutes (120 seconds) resulting in a <8% NFF (92% chest compression fraction).

The number of compressions delivered per minute may differ from the compression rate. The compressor may be delivering compressions at a rate of 0.6 second per cycle (100 compressions per minute), but if in each minute there are 10 seconds of held compressions, then the number of compressions delivered at this rate falls to 83 per minute. In the analysis of a 1-minute interval in which there were 15 seconds of held compressions, this same compression rate (0.6 second per cycle) results in a decrease to 75 compressions delivered to the patient. In an adult OHCA study, the use of a compression rate of 121 resulted in the number of compressions delivered being 64 per minute ( ). The accomplishment of 80 chest compressions per minute has been correlated with successful resuscitation in an animal model ( ). Resuscitation team members in roles of the compressor and the leader need to be aware of how many actual compressions are delivered per minute and minimize interruptions to keep the compression delivery rate above 80 per minute. If the patient is intubated, compressing at a rate of 100 per minute and stopping for only 10 seconds every 2 minutes to change compressors and perform pulse checks/rhythm analysis will result in 92 compressions delivered per minute. This effective delivery rate becomes even more important in a rate-dependent model.

Compression force is the pressure and the acceleration applied to the chest. Accelerometers are available to monitor and provide feedback about the compression force applied with each compression, but they are not typically available in intraoperative resuscitation. The compression depth is the amount of anterior-posterior displacement provided by a compression and is related to the compression force applied and the compliance of the chest wall. The recommended compression depth is 1.5 to 2 inches (38 to 50 mm) for adult patients and one-third to one-half the anterior-posterior chest diameter for children and infants. Adult and pediatric literature indicates that the minimum depth is not often achieved during resuscitation ( ; ). A pediatric manikin model of resuscitation achieved minimum depth recommendations in only 9.4% of chest compressions ( ). Compression depths were <38 mm for 37% of compressions during adult IHCA (mean depth 43 mm for all compressions) ( ) and for 62% of compressions during OHCA (mean depth 34 mm) ( ). A 5-mm increase in compression depth improved first shock success ( p = 0.028), illustrating the importance of adequate compression depth to the success of shocks delivered during IHCA ( ). Compression depth in a pediatric manikin model was 14 mm with the two-thumb technique but only 9 mm with the two-finger technique ( p = 0.001), indicating that the two-thumb technique is more effective for depth of compression ( ). In the operating room, the leader, the coach, or the recorder can assess the depth of compressions provided by the compressor and remind him or her to achieve the suggested depth. This continuous feedback is essential for effective resuscitation. ETCO 2 production should improve with increasing compression depth and/or force. The goal should be to maximize ETCO 2 levels, which should correlate with blood flow through the lungs and to vital organs.

It is important to allow full recoil of the chest and avoid any pressure during the release of compression (avoid leaning on chest) during the performance of effective chest compressions. Native chest recoil increases negative intrathoracic pressure, which augments venous blood return and stroke volume with subsequent compression. An animal model of incomplete recoil during active compression-decompression CPR resulted in increased intrathoracic pressure and reduced systemic arterial pressure, MPP, and cerebral perfusion pressure. This decrease in cerebral perfusion was related to the decrease in systemic arterial pressure rather than an increase in ICP ( ). In humans, the effect of incomplete recoil on intrathoracic pressure can be similar to the use of excessive rates or durations of ventilation and is likely to result in less effective CPR because of poor venous return ( ). In a study of pediatric IHCA, a feedback device alerted the compressor to leaning. Leaning was present in 97% of nonfeedback compressions versus 89% of feedback compressions when defined as force applied to the chest of >0.5 kg and in 83% of the nonfeedback compressions versus 71% of the feedback compressions when defined as a depth applied to the chest of >2 mm ( ). It is interesting that a feedback device during CPR reduced the rate of leaning but that leaning still occurred in most compressions. Prevention of leaning on the chest during release of compression is difficult and may require use of both feedback devices (i.e., defibrillators that can sense and give visual and audio feedback about leaning) and/or human observation and feedback by other compressors, the coach, or the leader. Fatigue likely contributes to this leaning phenomenon and its deleterious effects, emphasizing the need to change compressors at regular and frequent intervals. During an intraoperative arrest, a team approach can be tried in which the recorder, the coach, and the leader alert the compressor if full recoil appears to be inhibited by leaning on the chest between compressions.

Distribution of blood flow during CPR

Overall blood flow to tissues is decreased during CPR compared with the normal physiologic state. A redistribution of blood flow during CPR preferentially perfuses the heart and brain. This redistribution toward vital organ perfusion should enhance outcome despite a lower overall cardiac output, as the maintenance of myocardial blood flow during CPR is necessary for ROSC and the maintenance of cerebral blood flow determines the quality of neurologic outcome.

Distribution of blood flow to both the heart and brain during CPR is influenced by the development of regional gradients. Distribution of blood flow to the brain depends on development of three regional gradients: the suprathoracic gradient, the intracranial-extracranial gradient, and a caudal-rostral cerebral gradient. The intrathoracic-suprathoracic gradient provides flow of oxygenated blood from the chest to the upper extremities and head. Either venous collapse, secondary to elevated intrathoracic pressure, or closure of anatomic valves in the jugular system prevents the transmission of intrathoracic pressure to the suprathoracic venous system. When CPR is effective, arterial collapse does not occur and elevated intrathoracic pressure results in a gradient that promotes suprathoracic blood flow. The intracranial-extracranial gradient directs blood away from extracranial suprathoracic vessels and toward intracranial vessels. Alpha-adrenergic agonists constrict extracranial vessels but have little effect on intracranial vessels, resulting in increased intracranial blood flow. Animal models show that the use of the vasoconstrictor epinephrine increases intracranial blood flow while decreasing flow in the extracranial structures of the skin, muscle, and tongue. The cerebral caudal-rostral gradient involves intracranial vessels. The relatively low-flow state of CPR seems to increase the distribution of flow to caudal areas of the brain. Ischemia preceding CPR significantly increases the distribution of flow to these areas. This pattern of caudal redistribution of flow also occurs in other models of global ischemia and provides preferential perfusion of the brainstem. Although brainstem resuscitation is necessary for survival, this propensity for sparing of caudal circulation after either prolonged ischemia or prolonged CPR raises the concern for causing a survivor with severe neurologic injury or only brainstem function.

Myocardial blood flow does not have the advantage of the large extrathoracic pressure gradient that augments cerebral flow. The thoracic pump generates equal increases in all intrathoracic structures. This lack of a gradient can result in poor myocardial blood flow during external chest compressions. Several studies have shown much lower blood flow to the myocardium than to the cerebrum during external chest compressions. The type of CPR influences the production of myocardial blood flow. Methods that are more likely to cause direct cardiac compression, such as high-impulse or open-chest CPR, result in increased myocardial blood flow. Myocardial blood flow may be present only during relaxation of chest compression, correlating with a “diastolic” pressure, or in other methods seen during compressions correlating with a “systolic” pressure. Regional flow within the heart also changes during CPR, with a shift in the ratio of subendocardial:subepicardial blood flow from the normal 1.5:1 to 0.8:1. This ratio reverts to normal with epinephrine administration during resuscitation.

Blood flow to other organs during CPR is very much reduced compared with that in the brain and heart. The lack of valves in infrathoracic veins causes retrograde transmission of venous pressure and decreases the gradient for blood flow below the diaphragm in animals. Regional blood flows for infrathoracic organs (small intestine, pancreas, liver, kidney, and spleen) during CPR are usually less than 20% of prearrest rates and often close to zero. Administration of epinephrine during closed-chest CPR almost eliminates flow to the subdiaphragmatic organs (the exception is the adrenal glands, which are resistant to effects of epinephrine). Little information is available regarding blood flow to the lungs during CPR. Pulmonary blood flow occurs primarily at times of low intrathoracic pressure during closed-chest CPR. High extrathoracic venous pressure builds up during compression and results in pulmonary filling during relaxation as intrathoracic pressure falls. Resuscitation methods that lower intrathoracic pressure may augment pulmonary vascular filling. Leaning on the chest during relaxation of compression or maintenance of increased ventilation pressures may prevent the fall in intrathoracic pressure between chest compressions and decrease pulmonary venous return and blood flow. ETCO 2 measurements are an indicator of pulmonary blood flow (discussed later in this section).

Monitoring the effectiveness of resuscitative efforts

The brain and heart are the organs most likely to suffer irreversible damage if resuscitation efforts do not provide adequate blood flow and oxygen delivery. Table 57.6 lists several methods that are useful to determine whether resuscitation efforts are effective in restoring adequate perfusion to these vital organs. If resuscitation efforts are inadequate, interventions to improve effectiveness include improving performance of compressions (i.e., increasing depth, ensuring adequate rate, preventing leaning, or replacing a fatigued compressor), administering fluid to improve intravascular volume, and administering vasoconstrictors to improve vascular tone. If improvement attempts fail and resuscitation efforts are determined to be ineffective (as happens with prolonged arrest before CPR), the decision can be made that continued resuscitation is futile and that efforts should be terminated.

TABLE 57.6
Techniques for Monitoring Cardiopulmonary Resuscitation Effectiveness
Technique Monitoring Device Goal
Level of consciousness Examination Consciousness
Return of spontaneous circulation Examination, arterial catheter, ETCO 2 Spontaneous circulation
Pulse during compressions Examination Arterial pulsation
ETCO 2 Quantitative ETCO 2 >25 torr
Arterial diastolic (relaxation) pressure Arterial catheter >25–30 mm Hg
Mixed venous saturation Central venous catheter >30%
Venous-arterial CO 2 difference Arterial and central catheter Decreased difference
Amplitude of VF Electrocardiogram Increased amplitude
Frequency of VF Electrocardiogram Decreased frequency
AMSA ECG and software for analysis >13 mV Hz
Transthoracic impedance AED and software for analysis Decreased by compression
AED, Automated external defibrillator; AMSA, amplitude spectrum area; CO 2 , carbon dioxide; ETCO 2 , end-tidal carbon dioxide; VF, ventricular fibrillation.

The level of consciousness provides feedback about resuscitation efforts and can improve if resuscitation efforts are effective. Occasionally a patient with a nonperfusing rhythm or otherwise low cardiac output will regain consciousness during effective chest compressions only to become unresponsive when compressions are held. This cycle may recur repeatedly until a perfusing rhythm is restored. Although return of consciousness is evidence of highly effective resuscitative efforts, it is rare that the level of perfusion required can be accomplished and is more unlikely under anesthesia.

The ROSC is a more common indicator of adequate resuscitative efforts. It is a sign that perfusion to the heart muscle is enough to allow effective contractions. The temptation is often to hold resuscitation efforts when spontaneous ejection occurs, but spontaneous circulation may not be adequate or sustained and continued resuscitation efforts may be required. Continue compressions if spontaneous circulation does not adequately perfuse vital organs despite ROSC.

The palpation of a pulse can indicate that chest or cardiac compressions are generating significant arterial pressure. Unfortunately, feeling “a pulse” with compressions may represent only peak arterial pressure and not the presence of an adequate diastolic (relaxation) pressure necessary for coronary perfusion. An additional concern about reliance on palpation to determine the effectiveness of resuscitation is that the palpated artery is usually next to a large vein, and retrograde venous pulsations may occur in the absence of significant arterial blood flow. Retrograde venous femoral pulsations have been shown during CPR with a cross-clamped aorta and with ultrasound attempts at femoral venous cannulation. There are no data on when (or even if) palpation of a pulse during chest compressions correlates with ROSC or outcome.

One of the most useful ways to measure the effectiveness of chest or cardiac compressions in generating blood flow is to use quantitative ETCO 2 monitoring . Fortunately, ETCO 2 monitoring devices are readily available in anesthetizing locations. In low cardiac output states, including during CPR, the detection of ETCO 2 during compressions is dependent on the adequacy of compressor-generated pulmonary blood flow. The level of ETCO 2 increases as compressions become more effective at increasing pulmonary blood flow and the delivery of CO 2 to the lungs. ETCO 2 has been used to guide rate, depth, duty cycle, and hand position of chest compressions in an animal model ( ) and may result in better rates of ROSC and short-term survival than standard CPR ( ). These benefits were lost in the setting of prolonged (23-minute) asphyxial arrest prior to the onset of CPR ( ).

Low levels of ETCO 2 generated during compressions correlate with decreased levels of blood flow and decreased likelihood of ROSC ( ). During CPR, ETCO 2 measurements that are persistently <10 mm Hg predict an unlikely ability to achieve ROSC in adults. Some past studies have suggested that levels of ETCO 2 greater than 15 mm Hg predict ROSC in adults and children ( ; ; ). However, a meta-analysis by Hartman et al. (2014) noted an average ETCO 2 level of 25 mm Hg in patients who achieved ROSC. This value is significantly higher than the previously recommended goal of >10 to 15 mm Hg during CPR. The 2020 AHA recommendations for pediatric resuscitation are unable to recommend a specific target for ETCO 2 during CPR; instead, they focus on the utility of its measurement ( ). Certainly, ETCO 2 levels <10 to 15 mm Hg during CPR suggest that ROSC is unlikely and should prompt attempts to improve CPR (e.g., better compressions, fluid, or vasoconstrictor administration). The measurement of ETCO 2 during CPR has also been used to detect (1) low levels of cardiac output during pulseless electrical activity ( ), (2) ROSC during compressions ( ), and (3) the presence of spontaneous circulation during cardiopulmonary bypass ( ).

ETCO 2 measurement during CPR does not require an ETT. ETCO 2 levels measured during CPR with bag-mask or laryngeal mask ventilations also correlate with likelihood of achieving ROSC ( ). Other important considerations when monitoring ETCO 2 levels include the following: (1) The administration of bicarbonate can cause a transient elevation in ETCO 2 without an increase in blood flow and may be misinterpreted as improving CPR. (2) Epinephrine administration has been associated with a transient decrease in ETCO 2 despite an increase in MPP and may be misinterpreted as a worsening of CPR. The time frame of this decrease is usually short lived (<30 seconds) ( ). (3) The etiology of arrest influences the initial ETCO 2 levels during resuscitation. Higher initial ETCO 2 levels are seen after asphyxial arrest than fibrillatory arrest ( ). Fortunately, this bump in ETCO 2 during CPR after asphyxia washes out with 30 to 60 seconds of CPR. Despite these considerations, ETCO 2 monitoring during CPR is beneficial, and its use during CPR is recommended.

If invasive monitoring is in use at the time of an arrest, arterial pressure monitoring is also helpful to determine the effectiveness of resuscitative efforts. An arterial catheter is necessary to determine aortic diastolic pressure during the relaxation phase of compressions. If an arterial catheter is present, diastolic blood pressure (DBP) during CPR can be used as a surrogate for MPP when central venous access is unavailable; levels >15 to 20 mm Hg are necessary for, but do not guarantee, ROSC in adult patients ( ). An arterial catheter is also useful for measuring and providing real-time feedback for the effective rate of compressions. A low diastolic (relaxation) pressure (<15 to 20 mm Hg) noted on an arterial catheter waveform represents a low MPP and may help guide volume and vasopressor administration ( ; ). Suggested target levels for DBP during CPR are >25 mm Hg for infants and >30 mm Hg for children ( ).

A central venous catheter, if present, can be used to determine the central venous oxygen saturation during CPR. The level of venous blood oxygen saturation during CPR correlates with blood flow and likelihood of ROSC. Much like its use in patients with septic shock, venous oxygen saturation can determine the oxygen supply and demand balance. Patients with a mixed-venous oxygen saturation <30% are unlikely to have ROSC ( ).

The presence of both arterial and venous catheters allows simultaneous sampling of gases for calculation of the venous-arterial CO 2 difference . This difference is approximately 5 mm Hg during native circulation and increases significantly as perfusion falls. During hypoperfusion, tissue CO 2 increases, venous CO 2 increases, pulmonary blood flow falls, and normal ventilation removes a greater percentage of CO 2 from the reduced pulmonary blood flow and results in lower arterial CO 2 . This increase in PvCO 2 and decrease in Pa co 2 creates a venous-arterial difference that is inversely proportional to the blood flow produced by CPR. This situation may make a venous blood gas more reflective of the actual acid-base status than an arterial sample. As the effectiveness of CPR improves, this venous-arterial gradient decreases.

The amplitude and frequency of ventricular fibrillation (VF) can be determined from the electrocardiogram (ECG) or by specific software built into AEDs and monitored to determine effectiveness of resuscitation. Typically, the VF waveform is coarse initially (high amplitude, low frequency) and deteriorates over time during ineffective CPR or prolonged arrest to fine VF (low amplitude, high frequency). As heart perfusion during CPR improves, VF reverts to a coarse pattern that indicates an improved metabolic state and that the heart is better primed for successful defibrillation. An index of amplitude and frequency, the amplitude spectral area (AMSA) has been correlated with the MPP, ETCO 2 , and likelihood of ROSC in an animal model ( ). AMSA is calculated by software in the AED, and a value of ≥13 mV Hz has been regarded as a critical threshold for defibrillation success. VF waveforms may be used to guide CPR in this respect. One would expect a fine VF waveform to become coarser as effective chest compressions are delivered. If the VF waveform deteriorates, it may be helpful to reevaluate the effectiveness of chest compressions (depth, rate, duty cycle, hand position, etc.). Some newer-model defibrillators contain software that helps with rhythm analysis by extracting CPR artifact from the ECG waveform. The filtered signal allows continuous ECG analysis, avoids pauses for rhythm check, and improves preparation for defibrillation.

Transthoracic impedance monitoring (TTI) is possible during CPR using the gel-coated pads applied to the chest for defibrillation. The defibrillator software analyzes TTI continuously and provides feedback about the decrease in impedance related to increased blood movement through the chest during compressions. This technique can monitor the amount of blood flow generated by compressions and determine whether compressions continue to be effective or deteriorate with rescuer fatigue ( ). The amplitude change of TTI correlates with compression depth and MPP ( ). TTI has been used to detect ROSC in adults. Like a sudden spike in ETCO 2 during CPR, changes in the TTI waveforms can signify ROSC. These methods can lead to earlier detection of ROSC and eliminate the no-flow period during a pulse check ( ; ).

An additional benefit of monitoring TTI during CPR is the ability to detect the presence or loss of ventilation. Gas entry into the lungs with ventilation causes an increase in TTI. The sudden loss of the cyclical changes in TTI with ventilation may indicate displacement of the ETT during CPR ( ). Although loss of ETCO 2 is also used to indicate displacement of the ETT, ETCO 2 levels may be markedly diminished by low pulmonary blood flow during CPR. The disappearance of impedance changes related to the failure of air entry with ETT displacement may be more reliable in situations of extremely low ETCO 2 . TTI might eliminate the need to interrupt compressions to perform auscultation when ETT displacement is suspected.

Many methods are available to the anesthesiologist to determine the effectiveness of intraoperative resuscitation efforts. The equipment for quantitative determination of ETCO 2 and arterial diastolic pressure monitoring is most likely to be available in perioperative situations.

Vascular access for medication and fluid administration

Peripheral and central vascular access

Vascular access is crucial to effective administration of medications and fluids for resuscitation but may be difficult to achieve in children. During cardiac arrest, attempts to obtain peripheral venous access in infants and children should be limited (<90 seconds), and if unsuccessful, an intraosseous (IO) needle should be placed and/or drug administration through the ETT begun. IO drug administration is prioritized over endotracheal administration because of variability in blood concentrations after endotracheal administration ( ). All medications that can be given by IV delivery may be given by IO, but only a limited number of medications may be administered safely via an ETT. Central venous access may be attempted during cardiac arrest by skilled providers, but attempts should not delay administration of life-saving medications via peripheral IV or IO route.

The ideally placed intravascular catheter during CPR would provide ready access for the anesthesiologist and minimize interruption of resuscitation efforts. Peripheral IV access, IO access, and femoral IV access can usually be gained without interruption of airway management or chest compressions. Using a saline flush after medication administration via peripheral IV access, IO access, and central IV access when the catheter tip is below the diaphragm improves medication delivery to the heart in the low-flow state of CPR. A flush with 5 to 20 mL of normal saline should drive the medication into the central circulation (0.25 mL/kg was effective in animal studies). For most CPR events, peripheral IV access should be adequate for administration of resuscitation medications ( Table 57.7 ).

TABLE 57.7
Vascular Access During Cardiopulmonary Resuscitation
Route Characteristics
Peripheral venous access (IV)
  • Route of first choice if vascular access not present

  • Rapidly and easily placed

  • Any drug or fluid may be administered

  • Flush each drug with 0.25 mL/kg normal saline (5 mL infants, 10 mL children, 20 mL in adults)

Intraosseous access (IO)
  • May be easier to obtain in <6-year-old than IV, can use for any age

  • Any drug or fluid may be administered

  • Flush with 0.25 mL/kg normal saline (5 mL infants, 10 mL children, 20 mL adult)

Endotracheal route (TT)
  • Use only if no IV or IO access

  • Only administer naloxone, atropine, vasopressin, epinephrine, and lidocaine (NAVEL drugs) by TT

  • Note: TT drug delivery requires 2–10 times IV dose

  • Use 5 mL of normal saline in TT to increase distribution into distal bronchial tree (10 mL in adults)

Central venous catheter (CVC)
  • Central access is first choice if already in place

  • Place if no IV or IO is obtained

  • Requires flush if catheter tip is below diaphragm (same as IV or IO)

Cut-down saphenous
  • Use when other options have failed

  • Requires special skill, high complication rate

  • Flush like CVC or IV depending on tip position

CPR, Cardiopulmonary resuscitation; CVC, central venous catheter; IO, intraosseous; IV, intravenous; TT, tracheal tube.

Intraosseous access

IO cannulation provides a rapid and safe route to vascular access via the bone marrow; this space is a noncompressible venous plexus and is reliably available when peripheral venous access is limited from dehydration or peripheral vasoconstriction. Trained providers can obtain IO access in 30 to 60 seconds, with a first-attempt success rate of 80%. All drugs, crystalloid, colloids, and blood can be administered via this route. The onset and duration of action of emergency medications are the same when given by IO, central access, or peripheral access during native circulation.

The preferred site for placement of an IO needle in a child is the anterior tibia. Alternative sites include the distal femur, medial malleolus, and iliac crest. In older children and adults, the distal radius, distal ulna, proximal humerus, and sternum (risk of cardiac laceration) are also considered appropriate sites ( Fig. 57.3 ). Specially designed IO needles should be available to the pediatric anesthesiologist for such emergencies. Rapid deployment devices for IO needles have been developed and may increase ease of IO placement ( ; and see Chapter 40 : Anesthesia for Pediatric Trauma, Figs. 40.6 and 40.7 A and B). The most common complication from IO access is displacement of the needle and extravasation of fluid and medication (12%). Other rare complications include bone fracture, compartment syndrome, osteomyelitis, and fat embolism.

Fig. 57.3, Intraosseous needle in proximal tibia.

Intratracheal medication administration

The intratracheal route may be used for administration of lipid-soluble resuscitation medications. As most anesthetized children have this route available, it should be considered early, particularly if vascular access is a problem or access to extremities is limited. Concerns related to variable delivery of medication and duration of effect make IO administration preferable to endotracheal administration in situations where IV access is not available.

Medications that can be administered via the ETT are included in the NAVEL mnemonic ( n aloxone, a tropine, v asopressin, e pinephrine, and l idocaine). Studies suggest that similar doses achieve lower serum concentrations when given via the trachea than when given by the IV route. Because lower serum concentrations of epinephrine may produce predominately beta-2 adrenergic effects, causing vasodilation and decreased MPP, the recommended intratracheal dose of epinephrine is 10 times the intravascular dose (100 mcg/kg), with a maximum dose of 2 to 2.5 mg. Recommended intratracheal doses of atropine and lidocaine are two times the intravascular dose, whereas naloxone and vasopressin have no optimal dose recommendation. Drug administration via the endotracheal route may have a prolonged effect because of a reservoir of drug in the pulmonary tree. Prolonged effects of resuscitative medications can be detrimental after cardiac arrest because patients may have sustained afterload and myocardial oxygen demand. After tracheal administration, medication should be flushed in with normal saline, 2 mL in children and 5 mL in adolescents, and five manual ventilation breaths to deliver the medication into distal airways and alveoli. This technique is favored over catheter or feeding tube delivery via the trachea because of ease and practicality.

Medications for cardiopulmonary resuscitation

Vasoactive medications

Epinephrine and other adrenergic agonists

Vasoactive medications are used during cardiac arrest to restore spontaneous circulation. Adrenergic agonists are a class of vasoactive medications that stimulate responses from adrenergic receptors in the body, including alpha-1, alpha-2, beta-1, beta-2, and beta-3 receptors. The most common medications in this class used for CPR are epinephrine (adrenaline), norepinephrine, dopamine, and dobutamine. Epinephrine has been the medication of choice during CPR since the 1960s, when it was demonstrated that early administration of epinephrine during cardiac arrest improved success rates in resuscitation.

Epinephrine targets alpha- and beta-adrenergic receptors, causing an increase in systemic vascular resistance and subsequent rise in DBP. The relative importance of alpha- over beta-adrenergic agonist actions during CPR was shown when animals that received a beta-agonist and an alpha-antagonist were much less likely to be resuscitated than those treated with an alpha-agonist and a beta-antagonist. These data suggest that the alpha-agonist action of epinephrine is responsible for resuscitation after cardiac arrest. Support for this theory was demonstrated by reports that the effects of epinephrine during CPR are mediated by selective vasoconstriction of peripheral vessels, excluding vessels that supply the brain and heart. Epinephrine administration increases and maintains aortic pressure and myocardial and cerebral perfusion pressures; however, flow to nonvital organs (e.g., kidneys, liver, and small intestine) is severely decreased by intense vasoconstriction despite elevation in arterial pressures.

Effects on coronary blood flow.

In the beating heart, the myocardial contractile state is increased by beta-adrenergic action. During CPR, beta-adrenergic drugs may stimulate spontaneous myocardial contractions and increase intensity of VF, but this inotropic effect can result in increased intramyocardial wall pressure, decreased MPP, and diminished myocardial blood flow. In addition, beta-adrenergic stimulation increases myocardial oxygen demand by increasing cellular metabolism and oxygen consumption. The increased oxygen demand (produced by beta-adrenergic agonists) superimposed on the low myocardial blood flow available during CPR may contribute to ischemia.

The increase in, and maintenance of, aortic diastolic pressure provided by administration of alpha-adrenergic agonists during CPR are critical for coronary blood flow and successful resuscitation. Pure alpha-agonists (e.g., methoxamine and phenylephrine) have been used successfully during CPR. The absence of direct beta-adrenergic stimulation prevents an increase in myocardial oxygen uptake and results in a more favorable oxygen demand-to-supply ratio in the ischemic heart. The alpha-agonists maintain myocardial blood flow during CPR and produce successful resuscitation as effectively as epinephrine. Increased aortic pressures can be sustained during CPR in animal models with the pure alpha-agonist phenylephrine. Controversy exists about the merits of pure alpha-agonist drugs for resuscitation versus the potential detrimental beta-adrenergic effects when using epinephrine.

Effects on cerebral blood flow.

During CPR, adequate cerebral blood flow also depends on peripheral vasoconstriction with alpha-adrenergic agonists. Epinephrine and other alpha-agonist drugs produce selective vasoconstriction of noncerebral peripheral vessels that supply areas of the head and scalp (i.e., tongue, facial muscle, and skin) without causing cerebral vasoconstriction during CPR. Infusion of either epinephrine or phenylephrine has been reported to maintain cerebral blood flow and oxygen uptake in CPR models and produced similar neurologic outcome in 24 hours, whereas other investigators have reported epinephrine to be more beneficial in generating vital organ blood flow. These differences may have resulted from drug dosages that were not equipotent in generating vascular pressure or from epinephrine having either a vasoconstrictive or vasodilatory effect, depending on the balance of alpha- and beta-adrenergic actions.

Cerebral oxygen uptake may be increased by a central beta-adrenergic receptor effect if enough epinephrine crosses the blood-brain barrier (BBB) during or after resuscitation. When cerebral ischemia is brief and the BBB remains intact, epinephrine and phenylephrine have similar effects on cerebral blood flow and metabolism. Catecholamines may cross the BBB when mechanical disruption occurs or when enzymatic barriers to vasopressors (i.e., monoamine oxidase inhibitors) are overwhelmed during tissue hypoxia. During CPR, the BBB may also be disrupted by the large fluctuations in cerebral venous and arterial pressures generated during chest compressions or from the arterial pressure surge that occurs in a maximally dilated vascular bed after resuscitation. An increase in cerebral oxygen demand when cerebral blood flow is limited could adversely affect cerebral recovery. Infant models of an 8-minute cardiac arrest before CPR show disruption of the BBB with extravasation of protein through the BBB. These theoretical effects of catecholamines on cerebral circulation still need to be clarified and are not a contraindication to administration of epinephrine during cardiac arrest.

Dosage and frequency.

The 2020 AHA guidelines recommend epinephrine within the first 5 minutes from the start of chest compressions during cardiac arrest ( ). This is a change from the 2015 guidelines, which did not specifically state a time frame. The timing of the subsequent doses is being studied ( ; ), and the 2020 AHA guidelines still recommend repeating the dose every 3 to 5 minutes until ROSC. Practically, this can be achieved by dosing every 4 minutes with every-other-2-minutes breaks for the compressor change and rhythm analysis.

The recommended epinephrine dose remains 0.01 mg/kg (10 mcg/kg) IV or IO to a max dose of 1 mg. If IV or IO access is unavailable, epinephrine may be administered via the ETT at 0.1 mg/kg (100 mcg/kg), although IV and IO dosing produce a more reliable drug absorption and effect than in the ETT. High-dose IV epinephrine (HDE, 0.1 mg/kg [100 mcg/kg] or greater) is not recommended for resuscitation because of a lack of evidence for benefit over standard dosing (0.01 mg/kg [10 mcg/kg]) and concern for harm. Although early animal models of cardiac arrest and clinical studies indicated that HDE provides increased cerebral and coronary blood flow, subsequent animal models suggest a disproportionate rise in myocardial oxygen consumption. Initial case series in adults reported increased DBP and successful ROSC when HDE was administered. A nonrandomized, unblinded study reported seven pediatric patients treated successfully with HDE (0.2 mg/kg [200 mcg/kg]) but subsequent large randomized controlled trials (RCTs) of high-dose and standard-dose epinephrine showed no benefit of HDE on survival or neurologic outcome. A prospective, randomized trial in children compared high-dose (0.1 mg/kg [100 mcg/kg]) with standard-dose (0.01 mg/kg [10 mcg/kg]) epinephrine for inpatient cardiac arrest after failure of initial standard epinephrine dose and found equal ROSC but that survival at 24 hours and discharge was better in the standard-dose group ( ). A meta-analysis of these and other studies also found that HDE may benefit ROSC but provides no improvement in survival to discharge ( ). HDE may contribute to adverse effects that occur after resuscitation by causing myocardial ischemia, arrhythmias, hypertensive crisis, pulmonary edema, digitalis toxicity, hypoxemia, and cardiac arrest. HDE (0.1 mg/kg [100 mcg/kg]) may be considered in clinical situations refractory to standard dosing, such as beta-blocker or calcium channel overdose, severe anaphylaxis, or septic shock ( Box 57.3 ) ( ; ).

BOX 57.3
Data from American Heart Association.
Epinephrine Administration During CPR

Actions

  • Decreases perfusion to nonvital organs (alpha-adrenergic effect)

  • Improves coronary perfusion (aortic diastolic pressure) (alpha-adrenergic effect)

  • Increases intensity of ventricular fibrillation (beta-adrenergic effect)

  • Stimulates cardiac contractions (beta-adrenergic effect)

  • Intensifies cardiac contractions (beta-adrenergic effect)

Indications

  • Bradyarrhythmia with hemodynamic compromise

  • Asystole or pulseless arrest

Dosage

  • Bradycardia: 0.01 mg/kg intravenous or intraosseous or 0.1 mg/kg TT; repeat every 3–5 min at the same dose

  • Pulseless: First dose, 0.01 mg/kg intravenous or intraosseous or 0.1 mg/kg TT; repeat every 3–5 min

CPR, Cardiopulmonary resuscitation; TT, tracheal tube.

Outcome.

Reports of the use of epinephrine in cardiac arrest have looked at its effect on ROSC, survival to admission, survival to discharge, and neurologic outcomes. A systematic review of 14 RCTs involving OHCA resuscitation found increased ROSC and survival to admission with standard-dose epinephrine but no benefit in survival to discharge or neurologic outcome ( ). Another systematic review of 53 articles related to the use of vasopressors in cardiac arrest also found that epinephrine use was favorably associated with short-term but not long-term outcome, that vasopressin was an equivalent initial vasopressor, and that there are no alternative vasopressors that provide a long-term benefit compared with epinephrine ( ). A retrospective study of children with IHCA who received epinephrine for an initial nonshockable rhythm demonstrated that for every minute delay in administration of epinephrine, there was a significant decrease in ROSC, survival at 24 hours, survival to discharge, and survival with favorable neurologic outcome. Children who received epinephrine ≤5 minutes after CPR initiation were more likely to survive to discharge ( ). Other studies of pediatric OHCA also demonstrated that earlier epinephrine administration increased rates of ROSC, survival to ICU admission, survival to discharge, and 30-day survival ( ; ; ).

Dopamine and dobutamine

Dopamine and dobutamine are adrenergic agents usually used for vasopressor support after cardiac arrest (see Postresuscitation Care). Guidelines for postresuscitation support advocate their use because they cause less tachycardia, myocardial ectopy, and hypertension than epinephrine in patients who have experienced cardiac arrest. Unwanted decreases in systemic vascular resistance can result from their beta-adrenergic effects ( Table 57.8 ).

TABLE 57.8
Vasopressor Infusions in the Postarrest Period
Agent Dose Comments
Epinephrine
Dopamine
0.05–1.0 mcg/kg/min
2–20 mcg/kg/min
Inotrope, chronotrope
Inotrope, chronotrope; dilates the splanchnic vasculature at lower doses, pressor effect at higher doses
Dobutamine
Milrinone
2–20 mcg/kg/min
Load: 25–50 mcg/kg
Infusion: 0.5–1 mcg/kg/min Vasopressin??
Inotrope, decreased SVR
Inotrope, improves diastolic relaxation, decreased SVR
SVR, Systemic vascular resistance.

Phosphodiesterase inhibitors.

Milrinone is commonly used as an inotrope to support myocardial function during the perioperative period in children undergoing congenital heart surgery and may be useful in the postresuscitation period. The benefits of milrinone include inotropic, dromotropic, and lusitropic effects without chronotropic effect. The predominant side effect of milrinone is systemic vasodilation. Milrinone is usually loaded with a dose of 25 to 50 mcg/kg over 30 minutes, followed by an infusion of 0.5 to 1 mcg/kg per minute (see Table 57.8 ). In an animal model of VF cardiac arrest, a postresuscitation loading dose and maintenance infusion of milrinone improved stroke volume and sustained rhythm ( ).

Vasopressin.

Vasopressin is a pituitary hormone that binds to specific vascular receptors (V1) responsible for vasoconstriction and to renal tubule receptors (V2) that facilitate water reabsorption. l -Arginine vasopressin is the exogenous form traditionally used to treat diabetes insipidus and gastric hemorrhage. Additional indications for vasopressin include vasoplegic shock and cardiac arrest. Both endogenous and exogenous vasopressin are inactivated and cleared from plasma by the liver and kidneys, with an elimination half-life of 10 to 20 minutes.

In cardiac arrest, vasopressin has a theoretical advantage over epinephrine because it causes vasoconstriction without adrenergic activity (i.e., it does not increase myocardial oxygen demand at a time when oxygen delivery is limited). In addition, vasopressin may result in less ventricular ectopy and tachycardia in the postresuscitation period. These advantages may be offset by intense vasoconstriction after ROSC with the potential to worsen myocardial ischemia.

A metaanalysis of vasopressin use in animal studies of cardiac arrest found that vasopressin increases ROSC compared with placebo or adrenaline ( ). However, data in humans are not as strong. A large, randomized trial of vasopressin and epinephrine for the treatment of OHCA found no difference in hospital admission rate for patients with VF or pulseless electrical activity (PEA) but did show improved hospital admission rate and survival to discharge in patients treated with vasopressin for asystole ( ). Additionally, hospital admission and survival to discharge were better among patients treated with vasopressin and then epinephrine than among those treated with epinephrine alone ( ). Other large RCTs have failed to demonstrate a beneficial effect of vasopressin alone or in combination with epinephrine versus epinephrine alone for survival to discharge ( ; ; ; ). Systematic reviews comparing vasopressin to standard-dose epinephrine found no difference in outcomes ( ; ).

The pediatric literature concerning the use of vasopressin during CPR is limited. A pediatric animal model of asphyxial cardiac arrest found that ROSC was more likely in animals treated with epinephrine than with vasopressin ( ). In three case series, vasopressin or terlipressin (a vasopressin analog) were promising for ROSC, survival to discharge, and survival with good neurologic outcome ( ; ; ). A feasibility study of vasopressin rescue for cardiac arrest refractory to one dose of epinephrine found an increase in 24-hour survival but not in ROSC, survival to discharge, or neurologic outcome ( ). A retrospective review of vasopressin use during pediatric IHCA in a national registry showed that only 5% of children in cardiac arrest received vasopressin, those who received vasopressin had a longer duration of cardiac arrest, and its use was more common in an intensive care setting (77%). After multivariate analysis, vasopressin was associated with worse ROSC and no difference in 24-hour or discharge survival ( ). Thus the role of vasopressin in pediatric cardiac arrest is indeterminate and requires further study.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here